Polyarteritis Nodosa clinical trials
The registry lists 22 studies for Polyarteritis Nodosa across more than 10 countries. 6 are recruiting or about to start. 3 of them are mainly about Polyarteritis Nodosa (how this is decided). Per ClinicalTrials.gov, last updated 2026-10-29.
Get an email when these change. Save the Polyarteritis Nodosa studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
University of Pennsylvania (6) · University of South Florida (5) · Assistance Publique - Hôpitaux de Paris (2) · University of British Columbia (1) · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (1) · University of Oxford (1) · Fairview University Medical Center (1) · National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) (1)
What is being tested here
Drugs under test in Polyarteritis Nodosa studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
| Drug | Open | Phase 3 | All |
|---|---|---|---|
| Azathioprine | 0 | 1 | 2 |
| Cyclophosphamide | 0 | 0 | 1 |
| Prednisone | 0 | 0 | 1 |
| Methylprednisolone | 0 | 0 | 1 |
| Lamivudine | 0 | 0 | 1 |
| Methotrexate | 0 | 0 | 1 |
Drug classes tested here Antimetabolites 3
Who these studies take
Of the 6 Polyarteritis Nodosa studies recruiting now, 4 (67%) set no upper age limit and 2 (33%) stop at 75 or younger. 5 (83%) take children under 18. 1 (17%) are for women only and 0 (0%) for men only; 2 (33%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 5 (83%) | 5 (83%) |
| 18 | 6 (100%) | 5 (83%) |
| 30 | 5 (83%) | 4 (67%) |
| 40 | 5 (83%) | 4 (67%) |
| 50 | 5 (83%) | 4 (67%) |
| 65 | 4 (67%) | 4 (67%) |
| 75 | 4 (67%) | 4 (67%) |
| 85 | 4 (67%) | 4 (67%) |
Across all 22 studies, recruiting or not: 14% stop at 75 or younger and 14% at 65; 55% take children; 5% are for women only and 0% for men only; 9% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
Studies
Recruiting first, then most recently updated. Showing 22 of 22. search them.
- Studies of the Natural History, Pathogenesis, and Outcome of Idiopathic Systemic VasculitisRecruitingNCT022578661 country
- Vasculitis Pregnancy RegistryRecruitingNCT025935651 country
- Clinical Transcriptomics in Systemic Vasculitis (CUTIS)RecruitingNCT030043262 countries
- VCRC Tissue RepositoryRecruitingNCT029670682 countries
- One-Time DNA Study for VasculitisRecruitingNCT012413053 countries
- Pediatric Vasculitis InitiativeRecruitingNCT020061347 countries
- Low Dose Naltrexone to Improve Physical Health in Patients With VasculitisCompletedNCT03482479Phase 22 countries
- Association Corticosteroid/Azathioprine in Microscopic Polyangiitis/ Polyarteritis Nodosa or Eosinophilic Granulomatosis With Polyangiitis (Churg Strauss Syndrome)CompletedNCT00647166Phase 31 country
- Biologics in Refractory Vasculitis: A Trial of Biologic Therapy for Refractory Primary Non-ANCA Associated VasculitisTerminatedNCT05168475Phase 21 country
- Determining Disease Activity Biomarkers in Individuals With Polyarteritis NodosaCompletedNCT003154062 countries
- VCRC Patient Contact Registry Patient-Reported Data Validation StudyCompletedNCT021909421 country
- Journey of Patients With Vasculitis From First Symptom to DiagnosisCompletedNCT034102901 country
- American College of Rheumatology/European League Against Rheumatism (ACR/EULAR) Diagnostic and Classification Criteria for Primary Systemic VasculitisStatus unknownNCT0106620833 countries
- Impact of Vasculitis on Employment and IncomeCompletedNCT024762921 country
- Educational Needs of Patients With Systemic VasculitisCompletedNCT021909291 country
- Vasculitis Illness Perception (VIP) StudyCompletedNCT021909161 country
- Reproductive Health in Men and Women With VasculitisCompletedNCT021760701 country
- Treatment of Necrotizing Vasculitides for Patients Older Than 65 YearsCompletedNCT00307671Phase 41 country
- Cyclophosphamide Versus Methotrexate for Remission Maintenance in Systemic Necrotizing VasculitidesStatus unknownNCT00751517Phase 21 country
- Lamivudine for Chronic Hepatitis BCompletedNCT00001457Phase 21 country
- CHUSPAN PAN BP Treatment of Polyarteritis Nodosa and Microscopic Polyangiitis Without Poor-Prognosis FactorsStatus unknownNCT00400075Phase 41 country
- Autologous Peripheral Blood Stem Cell Transplantation in Patients With Life Threatening Autoimmune DiseasesStatus unknownNCT00006055Not applicable1 country